The size of the Asia Pacific anti-snoring devices market was valued at USD 0.15 billion in 2021 and is estimated to grow USD 0.25 billion by 2026, growing at a CAGR of 11.54% during the forecast period.
The Asia Pacific anti-snoring market is expected to grow exponentially during the forecast period resulting in a rise in the number of opportunities for the key stakeholders and players functioning in the anti-snoring business. Escalation of online promotion led to the emergence of innovative marketing strategies, and it is supposed to boost growth opportunities to the stakeholders in the market. Furthermore, increased focus of key players to develop novel and useful anti-snoring devices and surgical procedures are presumed to expand growth opportunities for everyone involved in the anti-snoring devices market. The market has a high potential to grow during the outlook period due to the patient being in a tapped pool in the region.
The rise in the prevalence of people with snoring problems and other sleeping disorders in the Asia Pacific is the primary factor contributing to the growth of the APAC anti-snoring devices market.
Increasing awareness among people regarding the devices available for snoring owing to intensified marketing strategies and effective use of online marketing is another significant factor contributing to the growth of the anti-snoring market in the Asia Pacific region. Other key factors fuelling the development of the market are an expansion of the healthcare sector, resulting in increased accessibility of advanced detecting devices and treatment procedures, rise account of alcohol and smoking in countries like India, and the emergence of technologically advanced products at regular intervals.
The key challenges the market players face are the ignorance of a large section of people who consider snoring a health issue, especially in countries like India. In addition, high costs associated with advanced snoring surgery procedures and ineffective snoring surgeries are other significant concerns limiting the growth of the Asia Pacific anti-snoring market.
This research report on the APAC anti-snoring devices market has been segmented and sub-segmented into the following categories.
By Product Type:
By Surgical Procedures:
Regionally, Asia Pacific is anticipated to register the highest growth rate during the forecast period in the global market due to the availability of a large pool of untreated individuals with a snoring condition and the high level of awareness associated with this condition.
The anti-snoring devices market in China is anticipated to be the most lucrative regional market in Asia-Pacific during the forecast period. Factors such as continually increasing population with snoring problems, presence of key market players in the region, and a large gap between the treated and yet to be treated number of patients.
The Indian anti-snoring devices market is forecasted to be growing at a healthy CAGR from 2021 to 2026. It is anticipated to grow at a high pace during the projection period due to factors such as a high percentage of the population with snoring problems and increasing awareness among the people regarding the available treatment procedures and devices.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the Asia Pacific anti-snoring devices market profiled in the report are Sleeping Well LLC., Apnea Sciences Corporation, Tomed Dr. Toussaint Gmbh, AccuMED Corp, Fisher & Paykel Healthcare, Apnea Sciences Corporation, ImThera Medical Inc., ResMed Inc., SomnoMed, Sleep Well Enjoy Life, Ltd., MEDiTAS Ltd, and Nasal Devices.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device Type
5.1.2 Oral Appliances/Mouthpieces
188.8.131.52 Mandibular Advancement Devices (MADS)
184.108.40.206.1 Non-Custom MADS
220.127.116.11.2 Custom-Made MADS
18.104.22.168 Tongue-Retaining Devices (TRDS)
"5.1.3 Nasal Devices
22.214.171.124 External Nasal Dilators (Nasal Strips)
126.96.36.199 Other Nasal Devices
5.1.4 Position Control Devices
5.1.5 Chin Straps
5.1.6 Tongue-Stabilizing Devices (TSDs)
"5.1.7 Epap Therapy Devices
5.1.8 Y-o-Y Growth Analysis, By Device Type
5.1.9 Market Attractiveness Analysis, By Device Type
5.1.10 Market Share Analysis, By Device Type
5.2 Surgical Procedures
5.2.2 Uvulopalatopharyngoplasty (UPPP)
5.2.3 Laser-Assisted Uvulopalatoplasty (Laup)
5.2.4 Radiofrequency Ablation (Somnoplasty)
5.2.5 Pillar Procedure
5.2.6 Injection Snoreplasty/Sclerotherapy
5.2.7 Palatal Stiffening Procedures
5.2.8 Other Anti-Snoring Surgical Procedures
5.2.9 Y-o-Y Growth Analysis, By TSurgical Proceduresype
5.2.10 Market Attractiveness Analysis, By Surgical Procedures
5.2.11 Market Share Analysis, By Surgical Procedures
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Device Type
220.127.116.11 By Surgical Procedures
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Device Type
126.96.36.199 By Surgical Procedures
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Device Type
220.127.116.11 By Surgical Procedures
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Sleeping Well LLC
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Apnea Sciences Corporation
8.3 Tomed Dr. Toussaint Gmbh
8.4 AccuMED Corp.
8.5 Fisher & Paykel Healthcare
8.6 Apnea Sciences Corporation
8.7 ImThera Medical Inc.
8.8 ResMed Inc.
8.10 Nasal Devices.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures